PMVP
Price
$1.08
Change
+$0.01 (+0.93%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
56.09M
13 days until earnings call
PULM
Price
$6.77
Change
+$0.30 (+4.64%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
24.73M
14 days until earnings call
Ad is loading...

PMVP vs PULM

Header iconPMVP vs PULM Comparison
Open Charts PMVP vs PULMBanner chart's image
PMV Pharmaceuticals
Price$1.08
Change+$0.01 (+0.93%)
Volume$1.3K
Capitalization56.09M
Pulmatrix
Price$6.77
Change+$0.30 (+4.64%)
Volume$1.76K
Capitalization24.73M
PMVP vs PULM Comparison Chart
Loading...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PMVP vs. PULM commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMVP is a Buy and PULM is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (PMVP: $1.08 vs. PULM: $6.77)
Brand notoriety: PMVP and PULM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PMVP: 53% vs. PULM: 39%
Market capitalization -- PMVP: $56.09M vs. PULM: $24.73M
PMVP [@Biotechnology] is valued at $56.09M. PULM’s [@Biotechnology] market capitalization is $24.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMVP’s FA Score shows that 0 FA rating(s) are green whilePULM’s FA Score has 0 green FA rating(s).

  • PMVP’s FA Score: 0 green, 5 red.
  • PULM’s FA Score: 0 green, 5 red.
According to our system of comparison, PULM is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PMVP’s TA Score shows that 5 TA indicator(s) are bullish while PULM’s TA Score has 5 bullish TA indicator(s).

  • PMVP’s TA Score: 5 bullish, 3 bearish.
  • PULM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than PULM.

Price Growth

PMVP (@Biotechnology) experienced а +5.88% price change this week, while PULM (@Biotechnology) price change was +7.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

PMVP is expected to report earnings on Aug 07, 2025.

PULM is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMVP($56.1M) has a higher market cap than PULM($24.7M). PULM YTD gains are higher at: -3.009 vs. PMVP (-28.477). PULM has higher annual earnings (EBITDA): -6.78M vs. PMVP (-84.3M). PMVP has more cash in the bank: 169M vs. PULM (10.8M). PULM has less debt than PMVP: PULM (0) vs PMVP (1.19M). PULM has higher revenues than PMVP: PULM (10M) vs PMVP (0).
PMVPPULMPMVP / PULM
Capitalization56.1M24.7M227%
EBITDA-84.3M-6.78M1,244%
Gain YTD-28.477-3.009947%
P/E RatioN/AN/A-
Revenue010M-
Total Cash169M10.8M1,565%
Total Debt1.19M0-
FUNDAMENTALS RATINGS
PULM: Fundamental Ratings
PULM
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PMVPPULM
RSI
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IAS6.880.31
+4.72%
Integral Ad Science Holding Corp
ONCY0.580.02
+2.95%
Oncolytics Biotech
BP29.000.40
+1.40%
BP plc
ICL6.670.09
+1.37%
ICL Group Ltd
ORIC5.190.02
+0.39%
Oric Pharmaceuticals

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with RCKT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+0.93%
RCKT - PMVP
46%
Loosely correlated
+4.06%
CLLS - PMVP
39%
Loosely correlated
+3.42%
XNCR - PMVP
39%
Loosely correlated
-0.28%
COGT - PMVP
38%
Loosely correlated
+0.89%
VERV - PMVP
37%
Loosely correlated
+5.67%
More

PULM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PULM has been loosely correlated with ORMP. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PULM jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
+4.64%
ORMP - PULM
33%
Loosely correlated
-0.43%
INM - PULM
30%
Poorly correlated
+1.02%
GERN - PULM
27%
Poorly correlated
+2.16%
TSHA - PULM
26%
Poorly correlated
N/A
PMVP - PULM
25%
Poorly correlated
+0.93%
More